Vertex and Alnylam orphan drugs set for EU approvalOrphan drugs for cystic fibrosis and the hereditary rare disease hATTR are on course for European approval after Share XVertex and Alnylam orphan drugs set for EU approvalhttps://pharmaphorum.com/market-access-2/chmp-vertex-symkevi-alnylam-onpattro/
